Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis in adults. In June, the ACR released an updated guideline for the treatment of rheumatoid arthritis.1 The guideline includes 44 recommendations—seven of which are strong and 37 conditional. It underscores the role of methotrexate as a cornerstone therapy and emphasizes minimizing glucocorticoids, when possible. It also includes new recommendations for specific high-risk groups. Learn more in our article.
Plus, a vast repository of new research related to RA was presented at ACR Convergence 2021. Come back soon to see what abstracts Jeffrey Curtis, MD, MS, MPH, considers the most likely to make an impact on clinical practice and future research.